Discontinuity in the cancer slope factor as it passes from high to low exposure levels - arsenic in the BFD-endemic area

Toxicology

Volumn 326, Issue , 2014, Pages 25-35

  Lamm, Steven H ^a,b,c   Robbins, Shayhan ^a   Chen, Rusan ^d   Lu, Jun ^e   Goodrich, Brian ^a   Feinleib, Manning ^b  

^a CEOH   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

^e AMERICAN UNIVERSITY   (United States)

Author keywords

Arsenic; Bladder cancer; Dose response; Low level exposure; Lung cancer; Southwest Taiwan

Indexed keywords

ARSENIC; WELL WATER; CARCINOGEN; WATER POLLUTANT;

ADULT; ARTICLE; BLADDER; CANCER MORTALITY; CANCER RISK; CONCENTRATION (PARAMETERS); ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; LUNG; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; WATER SUPPLY; ANALYSIS; ARSENIC POISONING; DOSE RESPONSE; ENDEMIC DISEASE; HEALTH; LUNG NEOPLASMS; MORTALITY; RISK FACTOR; TAIWAN; URINARY BLADDER NEOPLASMS; WATER POLLUTANT;

ARSENIC; ARSENIC POISONING; CARCINOGENS, ENVIRONMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDEMIC DISEASES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; RISK ASSESSMENT; RISK FACTORS; RURAL HEALTH; TAIWAN; URINARY BLADDER NEOPLASMS; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 84908349497     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2014.08.014     Document Type: Article

References (53)

1. Abernathy C.O., Chappell W.R., Meek M.E., Gibb H., Guo H.-R. Is ingested inorganic arsenic a threshold carcinogen?. Fundamen. Appl. Toxicol. 1996, 29:168-175.
2. American Water Works Association (AWWA) Standard Methods for the Examination of Water, Sewage, and Industrial Wastes 1955, 40-44. American Public Health Association, Inc., New York City. 10th ed.
3. Arnold L.L., Suzuki S., Yokohira M., Kakiuchi-Kiyota S., Pennington K.L., Cohen S.M. Time course of urothelial changes in rats and mice orally administrated arsenite. Toxicol. Pathol. 2013, 42(5):856-862.
4. Baastrup R., Sorenson M., Balstrom T., Frederiksen K., Larsen C.L., et al. Arsenic in drinking-water and risk for cancer in Denmark. Environ. Health Perspect. 2008, 116(2):231-237.
5. Bates M.N., Rey O.A., Biggs M.L., Hopenhayn C., Moore L.E., et al. Case-control study of bladder cancer and exposure to arsenic in Argentina. Am. J. Epidemiol. 2004, 159(4):381-389.
6. Bates M.N., Smith A.H., Cantor K.P. Case-control study of bladder cancer and arsenic in drinking water. Am. J. Epidemiol. 1995, 141(6):523-530.
7. Cantor K.P. Invited commentary: arsenic and cancer of the urinary tract. Am. J. Epidemiol. 2001, 153(5):419-421.
8. Chen C.-J., Chuang Y.-C., Lin T.-M., Wu H.-Y. Malignant neoplasms among residents of a Blackfoot disease-endemic area in Taiwan: high-arsenic well water and cancers. Cancer Res. 1985, 45:5895-5899.
9. Chen C.J., Kuo T.-L., Wu M.-M. Arsenic and Cancers. Lancet 1988, 1(8582):414-415.
10. Chen C.-J., Chen C.-W., Wu M.-M., Kuo T.-L. Cancer potential in liver, lung, bladder, and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer 1992, 66(5):888-892.
11. Ch I.-C., 'I, Blackwell R.Q. A controlled retrospective study of Blackfoot disease, an endemic peripheral gangrene disease in Taiwan. Am. J. Epidemiol. 1968, 88(1):7-24.
12. Chen K.-P., Wu H.Y. Epidemiologic studies of Blackfoot disease in Taiwan, China: 2. A study of sources of drinking water in relation to the disease, J. Formosa Med. Assoc. 1962, 61(7):611-617.
13. Celik I., Gallicho L., Boyd K., et al. Arsenic in drinking water and lung cancer: a systematic review. Environ. Res. 2008, 108(9):48-55.
14. Chen C.-L., Chiou H.-Y., Hsu L.-I., Hsueh Y.-M., Wu M.-M., Wang Y.-H., Chen C.-J. Arsenic in drinking water and risk of urinary tract cancer: a follow-Up study from northeastern Taiwan. Cancer Epidemiol. Biomarkers Prev. 2010, 19(1):101-110.
15. Chen C.-L., Chiou H.-Y., Hsu L.-I., Hsueh Y.-M., Wu M.-M., Chen C.-C. Ingested arsenic characteristics of well water consumption, and risk of different histological types of lung cancer in northeastern Taiwan. Environ. Res. 2010, 110:455-462.
16. Chiang H.-S., Hong C.-L., Guo H.-R., Chen T.-Y. Comparative Study on the high prevalence of bladder cancer in the Blackfoot disease endemic area in Taiwan. J. Formos Med. Assoc. 1988, 87(11):1074-1080.
17. Cohen S.M., Arnold L.L., Eldan M., Lewis A.S., Beck B.D. Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit. Rev. Toxicol. 2006, 36:99-133.
18. Guo H.-R. Cancer Risks Associated with Arsenic in Drinking Water. Environ. Health 2007, 115(7):A240-A339.
19. Karagas M.R., Totsteson T.D., Morris J.S., Demidenko E., Mott L.A., et al. Incidence of transitional cell carcinoma on the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 2004, 15:465-472.
20. Kuo T.-L. Arsenic content of artesian well water in endemic area of chronic arsenic poisoning. Rep. Inst. Pathol. Natl. Taiwan Univ. 1968, 20:7-13.
21. Kurttio P., Pukkala E., Kahelin H., Auvinen A., Pekkanen J. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ. Health Perspect. 1999, 107(9):705-710.
22. Lamm S.H., Byrd D.M., Kruse M.B., et al. Bladder cancer and arsenic exposure: differences in the two populations enrolled in a study in southwest Taiwan. Biomed. Environ. Sci. 2003, 16:355-368.
23. Lamm S.H., Engel A., Kruse M.B., Feinleib M., Byrd D.M., et al. Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 U.S Counties and 30 years of observation. J. Occup. Environ. Med. 2004, 46:298-306.
24. Lamm S.H., Kruse M.B. Arsenic ingestion and bladder cancer mortality-what do the dose-response relationships suggest about mechanism?. Hum. Ecol. Risk Assess. 2005, 11(2):433-450.
25. Lamm S.H., Engel A., Penn C.A., et al. Arsenic cancer risk confounded in southwest Taiwan data set. Environ. Health Perspect. 2006, 114(7):1077-1082.
26. Lamm S.H., Engel A., Penn C.A., et al. Cancer risks associated with arsenic. Environ. Health Perspect. 2007, 115(7):A340-A341.
27. Lamm S.H., Robbins S.A., Zhou C., Lu J., Chen R., Feinleib M. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150ug/L) well water arsenic levels - an exploration of the low-dose Poisson analysis. Regul. Toxicol. Pharm. 2013, 65:147-156.
28. Lewis D.R., Southwick J.W., Ouellet-Hellstorm R., Rench J., Calderon R.L. Drinking water arsenic in Utah: a cohort mortality study. Environ. Health Perspect. 1999, 107(5):359-365.
29. Lu F.-J., Guo H.-R., Chaing H.-S., Hong C.-L. Relationship between the fluorescent iIntensity of well water and the incidence rate of bladder cancer. J. Clin. Oncol. 1986, 1:134-143.
30. Michaud D.S., Wright M.E., Cantor K.P., Taylor P.R., Virtamo Albanes D. Arsenic concentrations in pre-diagnostic toenails and the risk of bladder bancer in a bohort study of male smokers. Am. J. Epidemiol. 2004, 169(9):853-859.
31. Mink P.A., Alexander D.D., Barraj L.M., Kelsh M.A., Tsujo J.-S. Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis. Regul. Toxicol. Pharm. 2008, 52:299-310.
32. Morales K.H., Ryan L., Kuo T.-L., Wu M.-M., Chen C.-J. Risk of internal cancers from arsenic in drinking water. Environ. Health Perspect. 2000, 108(7):655-661.
33. Mostafa M.G., McDonald J.C., Cherry N.M. Lung cancer and exposure to arsenic in rural Bangladesh. Occup. Environ. Med. 2008, 65(11):765-768.
34. National Research Council (NRC) Arsenic in Drinking Water. Subcommittee on Arsenic in Drinking Water, National Research Council 1999, National Academy of Sciences Press, Washington, D.C.
35. National Research Council (NRC) Arsenic in Drinking Water - 2001 Update. Subcommittee on Arsenic in Drinking Water, National Research Council 2001, National Academy of Sciences Press, Washington, D.C.
36. National Research Council (NRC) Critical Aspects of EPA's IRIS Assessment of Inorganic Arsenic - Interim report 2013, The National Academies Press, Washington, D.C.
37. Snow E.T., Sykora P., Durham T.R., Klein C.B. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?. Toxicol. Appl. Pharmacol. 2005, 20(Suppl. 2):557-564.
38. Steinmaus C., Yuan Y., Bater M.N., Smith A.H. Case-control study of bladder cancer and drinking water arsenic in the western United States. Am. J. Epidemiol. 2003, 158(12):1193-1201.
39. Steinmaus C.M., Ferreccio C., Romo J.A., Yuan Y., Cortes S., Marshall G., Moore L.E., Balmes J.R., Liaw J., Golden T., Smith A.H. Drinking water arsenic in northern Chile: high cancer risks 40 years after exposure cessation. Cancer Epidemiol. Biomarkers Prev. 2013, 22(4):623-630.
40. Suzuki S., Arnold L.A., Pennington K.L., Chen B., Naranmandurs H., Li X.C., Chen S.M. Dietary administration of sodium arsenite to rats: relations between dose and urinary concentrations of methylated and thio-metabolites and effects on the rat bladder epithelium. Toxicol. Appl. Pharmacol. 2010, 244:98-105.
41. Tsai S.-M., Wang T.-N., Ko Y.-C. Cancer mortality trends in a Blackfoot-disease endemic community of Taiwan following water source replacement. J. Toxicol. Environ. Health Part A 1998, 55:389-404.
42. Tseng W.-P. Blackfoot disease in Taiwan: a 30-year follow-up study. Angiology 1989, 40(6):547-558.
43. Tseng W.-P., Chu H.-M., How S.-W., et al. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 1968, 40:53-63.
44. Tsuji J., Alexander D.D., Perez V., Mink P.J. Arsenic exposure and bladder cancer: quantitative assessment of studies inhuman populations to detect risks at low doses. Toxicology 2014, 317C:17-30.
45. Department of Health, Education, and Welfare (DHEW) U.S. Eighth Revision International Classification of Diseases Adapted for Use in the United States (IDC8) 1968, U.S. Department of Health, Washington.
46. U.S.Environmental Protection Agency (EPA) Health Assessment Document for Inorganic Arsenic. Final Report 1984, Office of Health and Environmental Assessment, (EPA/600/8-83-021).
47. U.S.Environmental Protection Agency (EPA) Special Report on Ingested Inorganic Arsenic: Skin Cancer; Nutritional Essentiality 1998, Risk Assessment Forum, Washington, D.C, (EPA/625/3-87/013).
48. U.S.Environmental Protection Agency (EPA) National primary drinking water regulations: arsenic and clarifications to compliance and new source contaminants monitoring. Fed. Regist. 2001, 66(14):6975-7022. (January 2001).
49. U.S. Environmental Protection Agency (EPA), 2004. Release by Dr. Andrew E. Schulman, Washington, D.C.
50. U.S.Environmental Protection Agency (EPA) Toxicological Review of Ingested Inorganic Arsenic(CAS No. 7440-38-2) In Support of Summary Information on the Integrated Risk Information System (IRIS) 2005, U.S. Environmental Protection Agency, Washington DC.
51. U.S.Environmental Protection Agency (EPA) Toxicological Review of Inorganic Arsenic, in Support of Summary Information on the Integrated Risk Information System (IRIS) 2010, External Review Draft.
52. Wu M.M., Kuo T.-L., Hwang Y.-H., Chen C.-J. Dose-response relation between arsenic concentration in well water and mortality from cancer and vascular diseases. Am. J. Epidemiol. 1989, 130(6):1123-1132.
53. Yeh S. Relative incidence of skin cancer in Chinese in Taiwan: with special reference to arsenical cancer. Natl. Cancer Inst. Monogr. 1963, 10:81-107.